325 related articles for article (PubMed ID: 23482741)
1. Radiotherapy targeting cancer stem cells: current views and future perspectives.
Ogawa K; Yoshioka Y; Isohashi F; Seo Y; Yoshida K; Yamazaki H
Anticancer Res; 2013 Mar; 33(3):747-54. PubMed ID: 23482741
[TBL] [Abstract][Full Text] [Related]
2. [Cancer stem cells: Radiotherapeutic features and therapeutic targets].
Méry B; Rancoule C; Guy JB; Espenel S; Wozny AS; Simonet S; Vallard A; Alphonse G; Ardail D; Rodriguez-Lafrasse C; Magné N
Bull Cancer; 2016 Jan; 103(1):48-54. PubMed ID: 26702506
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells: targets and potential biomarkers for radiotherapy.
Krause M; Yaromina A; Eicheler W; Koch U; Baumann M
Clin Cancer Res; 2011 Dec; 17(23):7224-9. PubMed ID: 21976536
[TBL] [Abstract][Full Text] [Related]
4. Surface markers of hepatocellular cancer stem cells and their clinical potential.
Feng D; Wang N; Hu J; Li W
Neoplasma; 2014; 61(5):505-13. PubMed ID: 24712843
[TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
6. Targeting a cornerstone of radiation resistance: cancer stem cell.
Moncharmont C; Levy A; Gilormini M; Bertrand G; Chargari C; Alphonse G; Ardail D; Rodriguez-Lafrasse C; Magné N
Cancer Lett; 2012 Sep; 322(2):139-47. PubMed ID: 22459349
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cells: The potential of carbon ion beam radiation and new radiosensitizers (Review).
Baek SJ; Ishii H; Tamari K; Hayashi K; Nishida N; Konno M; Kawamoto K; Koseki J; Fukusumi T; Hasegawa S; Ogawa H; Hamabe A; Miyo M; Noguchi K; Seo Y; Doki Y; Mori M; Ogawa K
Oncol Rep; 2015 Nov; 34(5):2233-7. PubMed ID: 26330103
[TBL] [Abstract][Full Text] [Related]
8. [Cancer stem cells, cornerstone of radioresistance and perspectives for radiosensitization: glioblastoma as an example].
Chargari C; Moncharmont C; Lévy A; Guy JB; Bertrand G; Guilbert M; Rousseau C; Védrine L; Alphonse G; Toillon RA; Rodriguez-Lafrasse C; Deutsch E; Magné N
Bull Cancer; 2012 Dec; 99(12):1153-60. PubMed ID: 23228708
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma stem cells - mechanisms of chemoresistance and histone deacetylase inhibitors.
Khalil MA; Hrabeta J; Cipro S; Stiborova M; Vicha A; Eckschlager T
Neoplasma; 2012; 59(6):737-46. PubMed ID: 22862175
[TBL] [Abstract][Full Text] [Related]
10. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
[TBL] [Abstract][Full Text] [Related]
11. Radiation resistance: Cancer stem cells (CSCs) and their enigmatic pro-survival signaling.
Skvortsova I; Debbage P; Kumar V; Skvortsov S
Semin Cancer Biol; 2015 Dec; 35():39-44. PubMed ID: 26392376
[TBL] [Abstract][Full Text] [Related]
12. Low production of reactive oxygen species and high DNA repair: mechanism of radioresistance of prostate cancer stem cells.
Kim YS; Kang MJ; Cho YM
Anticancer Res; 2013 Oct; 33(10):4469-74. PubMed ID: 24123017
[TBL] [Abstract][Full Text] [Related]
13. Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage.
Park SY; Kim JY; Jun Y; Nam JS
Recent Pat Anticancer Drug Discov; 2018; 13(1):18-39. PubMed ID: 28971778
[TBL] [Abstract][Full Text] [Related]
14. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
[TBL] [Abstract][Full Text] [Related]
15. CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells.
Desai A; Webb B; Gerson SL
Radiother Oncol; 2014 Mar; 110(3):538-45. PubMed ID: 24440048
[TBL] [Abstract][Full Text] [Related]
16. Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.
Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Waki A; Mori T; Yoshii H; Oh M; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2010 May; 37(4):395-404. PubMed ID: 20447549
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells in radiation response: current views and future perspectives in radiation oncology.
Peitzsch C; Kurth I; Ebert N; Dubrovska A; Baumann M
Int J Radiat Biol; 2019 Jul; 95(7):900-911. PubMed ID: 30897014
[No Abstract] [Full Text] [Related]
18. Cancer stem cells and signaling pathways in radioresistance.
Chang L; Graham P; Hao J; Ni J; Deng J; Bucci J; Malouf D; Gillatt D; Li Y
Oncotarget; 2016 Mar; 7(10):11002-17. PubMed ID: 26716904
[TBL] [Abstract][Full Text] [Related]
19. The role of cancer stem cells (CD133(+)) in malignant gliomas.
Cho DY; Lin SZ; Yang WK; Hsu DM; Lin HL; Lee HC; Lee WY; Chiu SC
Cell Transplant; 2011; 20(1):121-5. PubMed ID: 20887676
[TBL] [Abstract][Full Text] [Related]
20. Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Mori T; Yoshii H; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2011 Feb; 38(2):151-7. PubMed ID: 21315269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
